All Articles Healthcare Pharmaceuticals

Pharmaceuticals

InsurersPharmaceuticalsProviders

Medicare’s GLP-1 program shows why discounts are not enough

The program has increased patient inquiries about eligibility and coverage, but the its success depends on comprehensive care that includes monitoring, counseling and follow-up, Dr. Cate Varney writes.